S&P 100
2.756,50
PKT
+37,31
PKT
+1,37
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.05.12 | AT&T halten | Independent Research GmbH | |
08.05.12 | Citigroup overweight | Barclays Capital | |
08.05.12 | Linde halten | Norddeutsche Landesbank (Nord/LB) | |
08.05.12 | ConocoPhillips equal-weight | Barclays Capital | |
07.05.12 | ExxonMobil halten | Independent Research GmbH | |
07.05.12 | Texas Instruments outperform | RBC Capital Markets | |
07.05.12 | Procter Gamble neutral | UBS AG | |
07.05.12 | Boeing neutral | UBS AG | |
07.05.12 | Cisco buy | UBS AG | |
07.05.12 | Abbott Laboratories outperform | RBC Capital Markets | |
07.05.12 | Intel buy | UBS AG | |
07.05.12 | Amazon outperform | RBC Capital Markets | |
07.05.12 | Visa outperform | RBC Capital Markets | |
07.05.12 | MasterCard outperform | RBC Capital Markets | |
07.05.12 | Linde buy | Société Générale Group S.A. (SG) | |
07.05.12 | Microsoft overweight | Barclays Capital | |
07.05.12 | United Parcel Service overweight | Barclays Capital | |
07.05.12 | Linde halten | Independent Research GmbH | |
07.05.12 | Johnson Johnson kaufen | Fuchsbriefe | |
07.05.12 | Oracle buy | Stifel, Nicolaus & Co., Inc. | |
07.05.12 | General Motors outperform | RBC Capital Markets | |
07.05.12 | General Motors buy | UBS AG | |
04.05.12 | IBM buy | Stifel, Nicolaus & Co., Inc. | |
04.05.12 | Microsoft buy | Stifel, Nicolaus & Co., Inc. | |
04.05.12 | Linde kaufen | Bankhaus Lampe KG | |
04.05.12 | Intel buy | Sarasin Research | |
04.05.12 | Cisco buy | Caris & Company, Inc. | |
04.05.12 | Linde neutral | WestLB AG | |
04.05.12 | Linde buy | Commerzbank Corp. & Markets | |
04.05.12 | Linde buy | Sarasin Research | |
04.05.12 | Linde halten | National-Bank AG | |
04.05.12 | Apple overweight | JP Morgan Chase & Co. | |
04.05.12 | MasterCard overweight | Barclays Capital | |
04.05.12 | Devon Energy overweight | Barclays Capital | |
04.05.12 | Visa strong buy | Raymond James Financial, Inc. | |
04.05.12 | Visa buy | Deutsche Bank Securities | |
03.05.12 | AT&T outperform | Oppenheimer & Co. Inc. | |
03.05.12 | Pfizer equal-weight | Barclays Capital | |
03.05.12 | CVS Health buy | UBS AG | |
03.05.12 | AT&T neutral | UBS AG |